Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 06/18/2013

Company Name Symbol %Change
STAAR SURGIC STAA
10.98%
LUMOS NETWOR LMOS
5.70%
INSTEEL IND IIIN
5.28%
ERICKSON AIR EAC
5.10%
ASSURED GUAR AGO
4.98%

Earnings Scorecard: Altera Corp

by Zacks Equity Research

November 06, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Earnings estimates for chipmaker Altera Corporation (ALTR - Analyst Report) have declined significantly after the company provided soft guidance for the fourth quarter of 2012 despite reporting better-than-expected results in the third quarter.
Altera reported a net income of $157.5 million or 49 cents per share in the third quarter of 2012, easily beating the Zacks Consensus Estimate of 46 cents per share.
Altera reported sales of $495.0 million in the third quarter of 2012, down 5% year over year but up 6% sequentially.
Guidance in Detail
However, Altera expects sales to be down 6% – 10% sequentially in the fourth quarter of 2012. This implies a revenue guidance of $445.5 million – $465.3 million.
The weak guidance prompted the majority of the analysts covering the stock to lower their estimates for 2012 and 2013.
For 2012, as many as 20 out of 21 analysts have reduced their forecast leading to a 5 cent decline in earnings estimates.
For 2013, the decline is steeper as 19 out of the 21 analysts have lowered their projections, leading to a 24 cent decline in the earnings estimates.
For the fourth quarter of 2012, 19 out of the 21 analysts cut their estimates, leading to an 8 cent decline in earnings estimates.
Management attributed the weakness in guidance to lower demand from two prime customers. One customer in the mainstream category products converted a high-volume design last year to an ASIC but recently discovered a technical limitation in the device, which required the customer to fill the gap with product from Altera in the third quarter.
The second customer has converted 2 high-volume designs, one in networking and one in wireless, both mainstream products from Altera to ASICs, amounting to approximately 4% of revenue in the third quarter.
Excluding these conversions, Altera projected a sequential decline of 1% to 5%, driven by the overall weak economic environment impacting all major market segments. Management projects gross margin of 69% – 70% in the fourth quarter, roughly in line with the third quarter.
Our Take
Altera and its prime rival Xilinx, Inc (XLNX - Analyst Report) together hold nearly 87% of the PLD market. However, Xilinx seems to have gained traction and has won back its lost market share over the past few months. This does not bode well for Altera in the coming quarters.
Margins have already peaked and it might not be sustainable in the long run. Hence, owing to the macroeconomic weakness, we downgrade our recommendation to Underperform from Neutral.
Our Underperform recommendation is supported by a Zacks #4 Rank, which translates into a short-term rating of Sell.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.